• 1
    Latt N, Conigrave K, Saunders JB, Marshall EJ, Nutt D. Addiction Medicine. Oxford ( UK ) : Oxford University Press; 2009.
  • 2
    Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: A narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94102.
  • 3
    Neale J, Tompkins C, Sheard L. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. Health Soc Care Community. 2008;16(2):14754.
  • 4
    Carr S, Goldberg DJ, Elliott L, Green S, Mackie C, Gruer L. A primary health care service for Glasgow street sex workers–6 years experience of the “drop-in centre’, 1989–1994. AIDS Care. 1996;8(4):48997.
  • 5
    Drumm RD, McBride DC, Metsch L, Neufeld M, Sawatsky A. I'm a health nut!, Street drug users' accounts of self-care strategies. J Drug Issues. 2005;35:60729.
  • 6
    McCoy CB, Metsch L, Chitwood DD, Miles C. Drug use and barriers to use of health care services. Subst Use Misuse. 2001;36:789806.
  • 7
    Stoove MA, Dietze PM, Aitken CK, Jolley D. Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug Alcohol Depend. 2008;96(3):2815.
  • 8
    French MT, McGeary KA, Chitwood DD, McCoy CB. Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med. 2000;50:170313.
  • 9
    Palepu A, Tyndall MW, Leon H, Muller J, O'Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. CMAJ. 2001;165(4):41520.
  • 10
    Western Australian Network of Alcohol and Other Drug Agencies. WANADA GP Access (Pilot) Project Evaluation Summary [Internet]. Perth ( AUST ) : WANADA; 2009 [cited 2012 Mar 8]. Available from:
  • 11
    Myers BJ. Primary health care for people who inject drugs in low and middle income countries: A response to “The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users.”. Int J Drug Policy. 2012;23(2):1056.
  • 12
    Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health. 1994;84(2):20710.
  • 13
    Stein MD, O'Sullivan PS, Ellis P, Perrin H, Wartenberg A. Utilization of medical services by drug abusers in detoxification. J Subst Abuse. 1993;5(2):18793.
  • 14
    Sheridan J, Wheeler A, Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? Harm Reduct J. 2005;2:25.
  • 15
    Wright NM, Tompkins CN. How can health services effectively meet the health needs of homeless people? Br J Gen Pract. 2006;56(525):28693.
  • 16
    McGeary KA, French MT. Illicit drug use and emergency room utilization. Health Serv Res. 2000;35(1 Pt 1):15369.
  • 17
    Gray SD, Fatovich DM, McCoubrie DL, Daly FF. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 2007;186(7):3369.
  • 18
    Topp L, Iversen J, Wand H, Day C, Kaldor J, Maher L. Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr. 2008;47(5):6328.
  • 19
    MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997. Collaboration of Australian NSPs. Med J Aust. 2000;172(2):5761.
  • 20
    MacDonald M, Wodak AD, Ali R, Crofts N, Cunningham PH, Dolan KA, et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust. 1997;166(5):23740.
  • 21
    STATA: Stata Statistical Software [computer program]. Version 11. College Station ( TX ) : Stata Corporation; 2009.
  • 22
    Australian Bureau of Statistics. 4839.0.55.001 – Health Services: Patient Experiences in Australia, 2009 [Internet]. Canberra ( AUST ) : ABS; 2010 [cited 2012 April 12]. Available from:
  • 23
    Cisneros GO, Douaihy AB, Kirisci L. Access to Healthcare Among Injection Drug Users at a Needle Exchange Program in Pittsburgh, PA. J Addict Med. 2009;3(2):8994.
  • 24
    Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the “narc” cabinet. J Gen Intern Med. 2002;17:32733.
  • 25
    Drumm RD, McBride DC, Metsch L, Page JB, Dickerson D, Jones B. “The rock always comes first”: drug users' accounts about using formal health care. J Psychoactive Drugs. 2003;35:4619.
  • 26
    Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999;34(4–5):72746.
  • 27
    Falck RS, Wang J, Carlson RG. Health status of illicit stimulant drug users in rural Ohio. J Psychoactive Drugs. 2007;Suppl 4:4015.
  • 28
    Chen CY, Lin KM. Health consequences of illegal drug use. Curr Opin Psychiatry. 2009;22(3):28792.
  • 29
    von Hippel C, Brener L. Specificity of discrimination: does it matter from whence it comes? J Appl Soc Psychol. 2012;42(4):102942.
  • 30
    Abouyanni G, Stevens LJ, Harris MF, Wickes WA, Ramakrishna SS, Ta E, et al. GP attitudes to managing drug and alcohol-dependent patients: a reluctant role. Drug Alcohol Rev. 2000;19:16570.
  • 31
    Silins E, Conigrave KM, Rakvin C, Dobbins T, Curry K. The influence of structured education and clinical experience on the attitudes of medical students towards substance misusers. Drug Alcohol Rev. 2007;26:191200.
  • 32
    Hopwood M, Treloar C, Bryant J. Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs (Abingdon Engl). 2006;13:6175.
  • 33
    Islam MM, Topp L, Conigrave KM, Beek Iv, Maher L, White A, et al. The reliability of sensitive information provided by injecting drug users in a clinical setting: clinician-administered versus audio computer-assisted self-interviewing (ACASI). AIDS Care. 2012;24(12):1496503.
  • 34
    Kwan L, Ho CJ, Preston C, Le V. Puentes clinic: an integrated model for the primary care of vulnerable populations. Perm J. 2008;12(1):105.
  • 35
    Lauretta E, Grau LE, Arevalo S, Catchpool C, Heimer R. Expanding harm reduction services through a wound and abscess clinic. Am J Public Health. 2002;92(12):191517.
  • 36
    Bruce RD. One stop shopping – bringing services to drug users. Int J Drug Policy. 2012;23(2):104.
  • 37
    Pollack HA, Khoshnood K, Blankenship KM, Altice FL. The impact of needle exchange-based health services on emergency department use. J Gen Intern Med. 2002;17(5):3418.
  • 38
    Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):14416.
  • 39
    van Beek I. Case study: accessible primary health care-a foundation to improve health outcomes for people who inject drugs. Int J Drug Policy. 2007;18(4):32932.
  • 40
    Norman J, Mugavin J, Swan A. Evaluation of the Primary Health Services. Melbourne ( AUST ) : Turning Point Alcohol and Drug Centre; 2006.
  • 41
    Day CA, Islam MM, White A, Reid SE, Hayes S, Haber PS. Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Aust J Prim Health. 2011;17:105.
  • 42
    Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. J Subst Abuse. 2001;13(1–2):1727.
  • 43
    Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf). 2005;27(1):626.
  • 44
    Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26(3):45360.
  • 45
    Bogstrand ST, Normann PT, Rossow I, Larsen M, Morland J, Ekeberg O. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department. Drug Alcohol Depend. 2011;117(2–3):1328.
  • 46
    Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Arch Surg. 2002;137(11):121722.
  • 47
    Moller LF, Matic S, van den Bergh BJ, Moloney K, Hayton P, Gatherer A. Acute drug-related mortality of people recently released from prisons. Public Health. 2010;124(11):6379.
  • 48
    Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison–a high risk of death for former inmates. N Engl J Med. 2007;356(2):15765.
  • 49
    Iversen J, Topp L, Maher L. Australian NSP Survey National Data Report 1995–2010: Prevalence of HIV, HCV and Injecting and Sexual Behaviour among NSP Attendees. Sydney ( AUST ) : University of New South Wales, Kirby Institute for Infection and Immunity in Society; 2011.
  • 50
    White B, Day C, Maher L. Self reported risk behaviour among injecting drug users: self versus assisted questionnaire completion. AIDS Care. 2007;19(3):4417.
  • 51
    Choi BC, Pak AW. A catalog of biases in questionnaires. Prev Chronic Dis. 2005;2(1):A13.
  • 52
    Topp L, Iversen J, Conroy A, Salmon AM, Maher L. Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Aust N Z J Public Health. 2008;32(1):347.